While the low dose infection resulted in a significant increase in the percentage of Mtb-specific CD4+IFN-γ+T cells as early as week 1 post-infection, this response was not observed in the high dose group till 3 weeks post infection (Figure 3A). This evidence concerns the gene CD4 and infection.